Cinematographer James Westlake explains why he used the Blackmagic PYXIS 12K on the independent feature Imagination of a Phoenix.

Video village, meet iris control: DCS launches lens link for long-range sets ...

Hello, and welcome to BD's First Fiscal Quarter 2026 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website at investor ...

Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call Transcript August 7, 2025 Becton, Dickinson and Company beats earnings expectations. Reported EPS is $3.68, expectations were $3.4.

I've been making films long enough now to know that the "correct" way to do things isn't always the best way. As an editor turned director, I've always been drawn to workflows that allow creative ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

In 2026, workflow automation tools have become a core requirement for enterprises looking to modernise operations, improve efficiency, and scale digital transformation initiatives. Manual hand-offs, ...

As a reminder, beginning October 1, we began operating under our previously disclosed new Becton, Dickinson and Company ...

While hospitals and health systems continue to face an array of significant challenges, human-centered innovations that pair data with agility are helping to improve caregiver experience and patient ...

Becton Dickinson and Co. (BDX) reported its first-quarter 2026 earnings, surpassing analyst expectations with an adjusted EPS of $2.91 against a forecast of $2.81. Revenue also exceeded projections, ...

Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The ...